Bridelia ferruginea produces antineuroinflammatory activity through inhibition of nuclear factor-kappa B and p38 MAPK signalling

Evidence-based Complementary and Alternative Medicine

Volumn 2012, Issue , 2012, Pages

  Olajide, Olumayokun A ^a,b   Aderogba, Mutalib A ^c   Okorji, Uchechukwu P ^a   Fiebich, Bernd L ^b,d  

^a UNIVERSITY OF HUDDERSFIELD   (United Kingdom)

^b UNIVERSITY OF FREIBURG   (Germany)

^c OBAFEMI AWOLOWO UNIVERSITY   (Nigeria)

^d VIVACELL BIOTECHNOLOGY GMBH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BRIDELIA FERRUGINEA EXTRACT; CYCLOOXYGENASE 2; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 14; MITOGEN ACTIVATED PROTEIN KINASE 3; NITRITE; PROSTAGLANDIN E2; TUMOR NECROSIS FACTOR ALPHA;

AFRICAN MEDICINE; ANIMAL CELL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BRIDELIA FERRUGINEA; CELL STIMULATION; ENZYME DEGRADATION; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; MEDICINAL PLANT; MICROGLIA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION;

EID: 84872133037     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2012/546873     Document Type: Article

References (28)

1. Okpako D. T., Traditional African medicine: theory and pharmacology explored. Trends in Pharmacological Sciences 1999 20 12 482 485 2-s2.0-0033404544 10.1016/S0165-6147(99)01406-6 (Pubitemid 30004019)
2. Oliver-Bever B., Medicinal Plants in Tropical West Africa 1986 London, UK Cambridge University Press
3. Iwu M. M., Handbook of African Medicinal Plants 1993 Boca Raton, Fla, USA CRC Press
4. Addae-Mensah I., Towards a Rational Scientific Basis for Herbal Medicine: A Phytochemist's Two-Decade Contribution 1992 Accra, Ghana Ghana Universities Press
5. Olajide O. A., Makinde J. M., Awe S. O., Effects of the aqueous extract of Bridelia ferruginea stem bark on carrageenan-induced oedema and granuloma tissue formation in rats and mice. Journal of Ethnopharmacology 1999 66 1 113 117 2-s2.0-0032980273 10.1016/S0378-8741(99)00006-9 (Pubitemid 29305423)
6. Olajide O. A., Makinde J. M., Okpako D. T., Awe S. O., Studies on the anti-inflammatory and related pharmacological properties of the aqueous extract of Bridelia ferruginea stem bark. Journal of Ethnopharmacology 2000 71 1-2 153 160 2-s2.0-0033916981 10.1016/S0378-8741(99)00201-9 (Pubitemid 30440664)
7. Olajide O. A., Okpako D. T., Makinde J. M., Anti-inflammatory properties of Bridelia ferruginea stem bark: Inhibition of lipopolysaccaride-induced septic shock and vascular permeability. Journal of Ethnopharmacology 2003 88 2-3 221 224 2-s2.0-0042330075 10.1016/S0378-8741(03)00219-8 (Pubitemid 37083450)
8. Akuodor G. C., Mbah C. C., Anyalewechi N. A., Idris-Usman M., Iwuanyawu T. C., Osunkwo U. A., Pharmacological profile of aqueous extract of Bridelia ferruginea stem bark in the relief of pain and fever. Journal of Medicinal Plants Research 2011 5 22 5366 5369
9. Adetutu A., Morgan W. A., Corcoran O., Antibacterial, antioxidant and fibroblast growth stimulation activity of crude extracts of Bridelia ferruginea leaf, a wound-healing plant of Nigeria. Journal of Ethnopharmacology 2011 133 1 116 119 2-s2.0-78650677375 10.1016/j.jep.2010.09.011
10. Nam N. H., Naturally occurring NF- B inhibitors. Mini-Reviews in Medicinal Chemistry 2006 6 8 945 951 2-s2.0-33746862576 10.2174/ 138955706777934937 (Pubitemid 44194381)
11. Folmer F., Jaspars M., Dicato M., Diederich M., Marine natural products as targeted modulators of the transcription factor NF- B. Biochemical Pharmacology 2008 75 3 603 617 2-s2.0-37849022679 10.1016/j.bcp.2007.07.044
12. Munoz L., Ammit A. J., Targeting p38 MAPK pathway for the treatment of Alzheimer's disease. Neuropharmacology 2010 58 3 561 568 2-s2.0-73449131129 10.1016/j.neuropharm.2009.11.010
13. Yong H. Y., Koh M. S., Moon A., The p38 MAPK inhibitors for the treatment of inflammatory diseases and cancer. Expert Opinion on Investigational Drugs 2009 18 12 1893 1905 2-s2.0-72249120832 10.1517/13543780903321490
14. Fiebich B. L., Biber K., Lieb K., Van Calker D., Berger M., Bauer J., Gebicke-Haerter P. J., Cyclooxygenase-2 expression in rat microglia is induced by adenosine A2a-receptors. GLIA 1996 18 2 152 160 2-s2.0-0030268068
15. Bhatia H. S., Candelario-Jalil E., de Oliveira A. C. P., Olajide O. A., Martínez-Sánchez G., Fiebich B. L., Mangiferin inhibits cyclooxygenase-2 expression and prostaglandin E2 production in activated rat microglial cells. Archives of Biochemistry and Biophysics 2008 477 2 253 258 2-s2.0-50349102157 10.1016/j.abb.2008.06.017
16. Olajide O. A., Heiss E. H., Schachner D., Wright C. W., Vollmar A. M., Dirsch V. M., Synthetic cryptolepine inhibits DNA binding of NF- B. Bioorganic and Medicinal Chemistry 2007 15 1 43 49 2-s2.0-33750932769 10.1016/j.bmc.2006. 10.018 (Pubitemid 44738596)
17. Jung H. W., Yoon C. H., Park K. M., Han H. S., Park Y. K., Hexane fraction of Zingiberis Rhizoma Crudus extract inhibits the production of nitric oxide and proinflammatory cytokines in LPS-stimulated BV2 microglial cells via the NF-kappaB pathway. Food and Chemical Toxicology 2009 47 6 1190 1197 2-s2.0-67349236219 10.1016/j.fct.2009.02.012
18. Surh Y. J., Chun K. S., Cha H. H., Han S. S., Keum Y. S., Park K. K., Lee S. S., Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: down-regulation of COX-2 and iNOS through suppression of NF- B activation. Mutation Research 2001 480-481 243 268 2-s2.0-0035451363 (Pubitemid 32744832)
19. Hehner S. P., Hofmann T. G., Dröge W., Schmitz M. L., The antiinflammatory sesquiterpene lactone parthenolide inhibits NF- b by targeting the I B kinase complex. Journal of Immunology 1999 163 10 5617 5623 2-s2.0-0033571108
20. Kwok B. H. B., Koh B., Ndubuisi M. I., Elofsson M., Crews C. M., The anti-inflammatory natural product parthenolide from the medicinal herb Feverfew directly binds to and inhibits I B kinase. Chemistry and Biology 2001 8 8 759 766 2-s2.0-0034879173 10.1016/S1074-5521(01)00049-7 (Pubitemid 32752455)
21. Kang B. Y., Chung S. W., Kim T. S., Inhibition of interleukin-12 production in lipopolysaccharide-activated mouse macrophages by parthenolide, a predominant sesquiterpene lactone in Tanacetum parthenium: Involvement of nuclear factor- B. Immunology Letters 2001 77 3 159 163 2-s2.0-0035797147 10.1016/S0165-2478(01)00211-5 (Pubitemid 32532070)
22. Collier H. O. J., Butt N. M., McDonald-Gibson W. J., Saeed S. A., Extract of feverfew inhibits prostaglandin biosynthesis. The Lancet 1980 2 8200 922 923 2-s2.0-0018941789 (Pubitemid 10014336)
23. Pugh W. J., Sambo K., Prostaglandin synthetase inhibitors in feverfew. Journal of Pharmacy and Pharmacology 1988 40 10 743 745 2-s2.0-0023771694
24. Fiebich B. L., Lieb K., Engels S., Heinrich M., Inhibition of LPS-induced p42/44 MAP kinase activation and iNOS/NO synthesis by parthenolide in rat primary microglial cells. Journal of Neuroimmunology 2002 132 1-2 18 24 2-s2.0-0036848107 10.1016/S0165-5728(02)00279-5 (Pubitemid 35333321)
25. Bhat N. R., Zhang P., Lee J. C., Hogan E. L., Extracellular signal-regulated kinase and p38 subgroups of mitogen- activated protein kinases regulate inducible nitric oxide synthase and tumor necrosis factor- α gene expression in endotoxin-stimulated primary glial cultures. Journal of Neuroscience 1998 18 5 1633 1641 2-s2.0-0032032424 (Pubitemid 28103071)
26. Chan E. D., Riches D. W. H., IFN- γ + LPS induction of iNOS is modulated by ERK, JNK/SAPK, and p38mapk in a mouse macrophage cell line. American Journal of Physiology 2001 280 3 C441 C450 2-s2.0-0035019373
27. Jijon H., Allard B., Jobin C., NF- B inducing kinase activates NF- B transcriptional activity independently of I B kinase γ through a p38 MAPK-dependent RelA phosphorylation pathway. Cellular Signalling 2004 16 9 1023 1032 2-s2.0-2942741018 10.1016/j.cellsig.2004.02.005 (Pubitemid 38798053)
28. Olson C. M., Hedrick M. N., Izadi H., Bates T. C., Olivera E. R., Anguita J., p38 mitogen-activated protein kinase controls NF- B transcriptional activation and tumor necrosis factor alpha production through RelA phosphorylation mediated by mitogen- and stress-activated protein kinase 1 in response to Borrelia burgdorferi antigens. Infection and Immunity 2007 75 1 270 277 2-s2.0-33846003856 10.1128/IAI.01412-06 (Pubitemid 46047902)